Overview
![DIA Learning](/en/-/media/diaglobal/images/tiles/323x240/courses/learning-lms-online-default-323x240.jpg?sc_lang=en)
Brought to you by DIA in cooperation with
In this session, we’ll discuss the three strategies you need to consider when planning your approach to submitting clinical trial assets in 2021. As privacy concerns continue to make headlines in the pharmaceutical space, sponsors face growing pressure to meet ever stricter regulatory requirements to anonymize clinical trial document submissions. To stay resilient, your organization must employ an approach that shields it from further regulatory shifts.
Have an account?